Shares of Akari Therapeutics PLC (AKTX) stock jumped 224% Wednesday. AKTX stock has gained 217.02% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives AKTX stock a score of 73 out of a possible 100.
That score is mainly influenced by a short-term technical score of 100. AKTX’s score also includes a long-term technical score of 100. The fundamental score for AKTX is 20. In addition to the average rating from Wall Street analysts, AKTX stock has a mean target price of $5.50. This means analysts expect the stock to lose 26.17% over the next 12 months.
What’s Happening with AKTX Stock Today
Akari Therapeutics (AKTX) stock has risen 26.27% while the S&P 500 has fallen -0.1% as of 10:38 AM on Thursday, Mar 14. AKTX stock has gained $1.55 from the previous closing price of $5.90 on volume of 13,794,696 shares. Over the past year the S&P 500 is up 2.14% while AKTX has gained 217.02%. AKTX stock lost -$2.84 share in the over the last 12 months.